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Research
Cadmium is a widespread environmental 
pollutant (Nordberg et al. 2007). There is 
accumulating data of toxic effects on kid-
ney (Buchet et al. 1990; de Burbure et al. 
2003; Järup et al. 2000; Nishijo et al. 2006; 
Suwazono et al. 2006) and bone (Åkesson 
et al. 2006; Alfven et al. 2004; Gallagher 
et al. 2008; Schutte et al. 2008; Staessen 
et al. 1999) at urinary cadmium concentra-
tions < 2.5 µg/g creatinine, previously con-
sidered to represent a safe exposure [Joint 
Food and Agriculture Organization of the 
United Nations (FAO)/World Health 
Organization (WHO) Expert Committee 
on Food Additives 2003]. A precautionary 
approach in the risk assessment of cadmium 
is further supported by recent findings sug-
gesting increased risk of cancer and overall 
mortality in relation to low-level cadmium 
exposure (Åkesson et al. 2008; Nawrot et al. 
2006, 2008), as well as variation in suscepti-
bility (Vahter et al. 2007).
Diet is the major source of cadmium 
exposure in nonsmokers (Nordberg et al. 
2007). The concentrations of cadmium in 
food vary considerably, but often foods of 
plant origin, such as cereals, potatoes, roots, 
and vegetables, are the major contributors to 
the exposure (Olsson et al. 2002). Cadmium 
accumulates mainly in the kidneys, and the 
kidney concentration of the metal is reflected 
in the concentration in urine, which thereby 
can be used as a marker of long-term cad-
mium exposure (Nordberg et al. 2007). 
Urinary cadmium concentrations are there-
fore commonly used as a surrogate for the 
body burden in health risk assessment. In 
order to perform a reliable and comprehen-
sive assessment of the health risks associated 
with long-term exposure to cadmium in food, 
data on dietary intake of cadmium need to be 
related to the internal dose over many years.
To assess the variation in the associa-
tion between dietary cadmium intake and 
urinary cadmium in the general population, 
various individual physiologic parameters 
affecting the internal dose of cadmium need 
to be taken into account. Parameters such 
as gastrointestinal absorption and biologi-
cal half-life (Nordberg et al. 2007) affect the 
target dose of cadmium in the body and may 
vary among individuals. Toxicokinetic (TK) 
models have been developed for cadmium, 
such as the Nordberg-Kjellström’s physio-
logically based toxicokinetic (PBTK) model 
(Kjellström 1971; Kjellström and Nordberg 
1978) and further developments thereof 
[see Supplemental Material (doi: 10.1289/
ehp.0800317.S1)], hereafter desig  nated as 
the “eight-compartment model.” A simpler 
one-compartment model has been used to 
predict urinary cadmium from food-cadmium 
intake [Kjellström 1971; WHO/International 
Program on Chemical Safety (IPCS) 1992]. 
Neither model has, however, been tested or 
validated in humans based on individually 
paired dietary and urinary cadmium data. 
Furthermore, the quantification of the 
between-person variability in a population 
is a crucial issue in risk assessment in order 
to build a robust statistical link between 
the urinary concentrations and the intake. 
Intervariability in a population has never been 
fully integrated or quantified in the models 
from the literature, leaving risk assessors with 
the use of uncertain safety factors in order to 
protect a given proportion of the population.
Based on new individual data of estimated 
long-term dietary cadmium intake and meas-
ured urinary cadmium concentrations, the 
aims of the present study were to a) quantita-
tively assess and compare the eight-compart-
ment PBTK model with the one-compartment 
TK model in terms of individual urinary cad-
mium predictions; b) integrate in the model 
and quantify the between-person variability 
in the population of cadmium toxicokinetics; 
and c) estimate the population distribution of 
daily cadmium intakes corresponding to a pre-
defined urinary cadmium concentration. The 
overall aim is to refine cadmium risk assess-
ments in food and environment.
Materials and Methods
Study population. The Swedish Mammography 
Cohort (SMC) was established in 1987–1990, 
when all 90,303 women residing in two coun-
ties in central Sweden, and born between 1914 
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Ba c k g r o u n d: Cadmium is a widespread environmental pollutant that has been shown to exert 
toxic effects on kidney and bones in humans after long-term exposure. Urinary cadmium concentra-
tion is considered a good biomarker of accumulated cadmium in kidney, and diet is the main source 
of cadmium among nonsmokers.
oB j e c t i v e: Modeling the link between urinary cadmium and dietary cadmium intake is a key step 
in the risk assessment of long-term cadmium exposure. There is, however, little knowledge on how 
this link may vary, especially for susceptible population strata.
Me t h o d s : We used a large population-based study (the Swedish Mammography Cohort), with 
repeated dietary intake data covering a period of 20 years, to compare estimated dietary cadmium 
intake with urinary cadmium concentrations on an individual basis. A modified version of the 
Nordberg-Kjellström model and a one-compartment model were evaluated in terms of their predic-
tions of urinary cadmium. We integrated the models and quantified the between-person variability 
of cadmium half-life in the population. Finally, sensitivity analyses and Monte Carlo simulations 
were performed to illustrate how the latter model could serve as a robust tool supporting the risk 
assessment of cadmium in humans.
re s u l t s: The one-compartment population model appeared to be an adequate modeling option to 
link cadmium intake to urinary cadmium and to describe the population variability. We estimated 
the cadmium half-life to be about 11.6 years, with about 25% population variability.
co n c l u s i o n s: Population toxicokinetic models can be robust and useful tools for risk assessment of 
chemicals, because they allow quantification and integration of population variability in toxicokinetics.
key w o r d s : alternative model development, Bayesian inference, cadmium toxicokinetics, popula-
tion variability, risk assessment, toxicokinetic models, urinary cadmium. Environ Health Perspect 
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and 1948, received a mailed invitation to be 
screened by mammography. Enclosed with 
this invitation was a six-page questionnaire 
regarding diet, body size, and education; 74% 
of women completed the questionnaire. In 
the autumn of 1997, a second questionnaire, 
expanded to include about 350 items concern-
ing diet and other lifestyle factors (including 
smoking habits), was sent to all 56,030 par-
ticipants who were still alive and living in the 
study area; 39,277 women (70%) completed 
this questionnaire.
In 2004, a validation study of cadmium 
intake was initiated in a subcohort of women. 
After completion of a food frequency ques-
tionnaire (FFQ), women living in the town 
of Uppsala were successively invited for 
blood and urine sampling and their weight 
was recorded. Between 2004 and 2007, data 
from a total of 1,519 women (56–70 years 
of age) were collected. After excluding those 
with implausible values for total energy intake 
(three standard deviations from the mean 
value of loge-transformed energy intake; n = 
26) and women who had ever smoked (n = 
813), 680 women remained for the model-
ing analysis. The study was approved by the 
Regional Ethical Review Board in Stockholm, 
Sweden, and written informed consent was 
obtained from each participant. 
Dietary assessment. An FFQ with 67, 96, 
and 123 food items was used to assess diet 
at baseline in 1987–1990, in 1997, and in 
2004–2007, respectively. The women were 
asked to report how often, on average, they 
had consumed each food item during the pre-
vious 6 months (baseline) or the past year 
(1997 and 2004–2007 FFQs). The question-
naires had eight mutually exclusive predefined 
categories for frequency of consumption, 
ranging from never/seldom to more than 
three times a day. For some commonly con-
sumed foods such as bread, coffee, tea, and 
dairy products, there were open questions. 
The baseline FFQ has been validated in a sub-
sample of 129 women randomly chosen from 
the study population. The Pearson correla-
tion coefficients (r) between the FFQ and the 
mean of four 1-week weighted diet records 
were between 0.5 and 0.8 for the main 
cadmium-contributing foods. In a study of 
57 Swedish women, dietary cadmium intake, 
assessed in duplicate diets, correlated well 
with tissue cadmium accumulation as assessed 
by the urinary excretion of the metal; r = 0.7 
(Åkesson A, unpublished data).
Data of cadmium concentration in each 
of the different food items in the FFQ were 
obtained from the Swedish National Food 
Administration (NFA; Uppsala, Sweden) 
(Becker and Kumpulainen 1991; Jorhem 
and Sundstrom 1993; Jorhem et al. 2001), 
as previously described (Åkesson et al. 2008). 
In order not to compromise the quality of 
the data, we excluded analyses performed 
before 1980, with the exception of butter, 
margarine, and oils (analyzed 1976–1978), 
for which later results were lacking. For only 
a few food items (e.g., certain vegetables, 
fruits, and some types of bread) for which 
no Swedish data were available, Finnish 
(Tahvonen and Kumpulainen 1994, 1995) 
and Danish (Larsen et al. 2002) data were 
used. Cadmium content in prepared dishes 
was calculated based on a recipe database from 
the NFA and on the cadmium concentration 
in each ingredient. The exposures from air 
(< 1% of total exposure; Vahter et al. 1991) 
and drinking water (community-provided tap 
water and private wells; Olsson et al. 2002) 
were low and not included.
The individual average cadmium intake 
of the women in the study cohort was cal-
culated based on the questionnaires used at 
baseline (1987–1990), 1997, and 2004–2007, 
by multiplying the frequency of consumption 
of each food item by its cadmium content per 
age-specific serving (≤ 65, > 65 years). The 
age-specific serving sizes were based on mean 
values from weighted foods recorded during 
four 1-week periods 3–4 months apart by ran-
domly selected women from the cohort (Wolk 
A, unpublished data). We adjusted cadmium 
for total energy intake of 1,700 kcal using the 
residual-regression method (Willett 1998).
Urinary cadmium assessment. The con-
centration of cadmium was determined in 
the first-void morning urine, which was col-
lected in urine cups that had been tested free 
from contamination and transferred to nitric 
acid–washed 13-mL polypropylene tubes. To 
minimize the risk of cadmium contamina-
tion of urine, the women received detailed 
sampling instructions. The samples were 
stored upon arrival at the laboratory at –80°C 
until analysis. Cadmium concentrations were 
measured using inductively coupled plasma 
mass spectrometry (Agilent 7500ce, Agilent 
Technologies, Waldbronn, Germany) with 
the collision cell in helium mode. Cadmium 
solutions for external calibration were pre-
pared fresh before every run from a 10.1 mg/L 
stock solution (ICP Multi Element Standard 
Solution VI CertiPUR; Merck, Darmstadt, 
Germany). The urine samples were thawed in 
room temperature and then diluted 10 times 
with 1% nitric acid. Cadmium isotope 111 
was measured and calculations were made with 
ChemStation software (Agilent Technologies).
For quality control purposes, commer-
cial reference materials (Seronorm Trace 
Elements Urine, ref. no. 201205, lot no. 
NO2525;Seronorm Trace Elements Urine 
Blank, ref. no. 201305, lot no. OK4636; 
SERO AS, Billingstad, Norway) were ana-
lyzed. Mean cadmium concentrations in the 
Seronorm samples were 4.80 ± 0.13 µg/L 
(n = 68; recommended value 5.06 ± 0.22) 
and 0.24 ± 0.03 µg/L (n = 121; recommended 
value 0.31 ± 0.05), respectively. The coef-
ficients of variation (CVs) were 2.6% and 
13.0%, respectively. The limit of detection, 
calculated as three times the standard devi-
ation of the blank values, was 0.003 µg/L. 
Because TK models were available only for 
creatinine-adjusted data, all urinary cadmium 
concentrations were expressed as micrograms 
per gram of urinary creatinine.
TK models. Two modeling approaches were 
investigated and compared. First, we considered 
a modified version of the eight-compartment 
PBTK model [Kjellström 1971; Kjellström and 
Nordberg 1978; see Supplemental Material 
(doi: 10.1289/ehp.0800317.S1)]. This model 
describes cadmium absorption, transport, and 
excretion via differential equations. Default gas-
trointestinal absorption fraction value was set 
to 0.1 (i.e., 10%). Red blood cell and plasma 
default volumes were set to 2.2 L and 3 L, 
respectively. Most of the parameter values were 
taken from Diamond et al.(2003), including 
the growth curve describing how body weight 
grows with age.
Second, we considered an alternative one-
compartment model (Kjellström 1971). Such 
a simpler model focuses on the kidney accu-
mulation and urinary excretion, making rough 
and global assumptions on the other path-
ways. In cases of poor prior knowledge of the 
physiologic parameters involved in cadmium 
kinetics, it allows a simplified and parsimoni-
ous description of cadmium excretion, hence 
facilitating further statistical evaluations, such 
as the evaluation of population variability or 
integration of intraindividual variability.
The one-compartment model consid-
ered here is a standard first-order elimination 
model with bolus administration (see, e.g., 
Gibaldi and Perrier 1982). For a given intake 
of cadmium (d0) at time 0, the accumulated 
amount of cadmium in the kidney at time t is 
calculated as
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where Abs is the gastrointestinal absorption 
coefficient (%), frackidney is the fraction of cad-
mium transported to kidney (%), coefcortex 
is the coefficient translating cadmium in the 
whole kidney into cadmium in the kidney 
cortex, and weightkidney is the kidney weight 
(kilograms) assumed to be proportional to 
body weight.Variability of cadmium toxicokinetics in humans
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We considered repeated exposure to cad-
mium as yearly bolus doses, from birth (year i 
= 0) until the current age (year i = t), as shown 
in Equation 3, where the sum is a yearly 
dietary addition of cadmium to the kidney 
accumulation, from birth until current age:
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The urinary cadmium concentration was 
assumed to be proportional to the cadmium 
concentration in the kidney cortex, so the uri-
nary cadmium concentration (in micrograms 
per gram of creatinine) at day t is obtained by
  Cdurine(t) = fu × Cdkidney (t),  [4]
where fu is the ratio between cadmium in 
urine (micrograms per gram of creatinine) 
and in kidney cortex (micrograms per kilo-
gram of kidney cortex).
Finally, in the case where dose per kilo-
gram of body weight is assumed to be constant 
over the lifetime, the equation of the model 
can be simplified into the more classical one:
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where d stands for the cadmium intake. 
This simpler form without any sum prevents 
numerical problems and can be derived after 
standard algebraic calculations under the 
assumption that cadmium intake per kilo-
gram body weight did not vary over time.
Furthermore, we assumed that the daily 
cadmium intake was proportional to the body 
weight for each individual. This assumption is 
supported by the results from the third U.S. 
National Health and Nutrition Examination 
Survey (NHANES III) as reported by 
Choudhury et al. (2001), who observed no 
substantial difference among age groups in 
the daily cadmium intake per kilogram of 
body weight (except for young children). This 
assumption is further supported by the out-
come of the trend analysis. We calculated for 
each individual the mean yearly cadmium 
intake over the three measurement periods as 
a proxy for the average long-term cadmium 
intake. The population mean of the cad-
mium half-life in the kidney was set to vary 
between 10 and 30 years. Such quantitative 
prior information as well as possible ranges 
for the parameter (fk × fu) were incorporated 
using Bayesian inference (described under 
“Statistical methods and models”).
We constructed the potential range for 
the aggregate factor fk coefficient based on the 
following biological data:
•	We	assumed	the	gastrointestinal	absorption	
coefficient among women to range from 1% 
to 10% (Flanagan et al. 1978; Nordberg 
et al. 2007).
•	The	fraction	of	cadmium	transported	to	
kidney is generally estimated to be around 
one-third (Kjellström and Nordberg 1978; 
Nordberg et al. 1985).
•	We	assumed	the	coefficient	translating	cad-
mium in the whole kidney into cadmium 
in the kidney cortex to be 1.25 (Nordberg 
et al. 1985; Svartengren et al. 1986).
•	We	assumed	the	kidney	weight	to	be	
0.43% of total body weight, based on kid-
ney weights of 0.235 kg and 0.3 kg at body 
weights of 55 kg and 70 kg, respectively 
(Kjellström and Nordberg 1978; Nordberg 
et al. 1985).
Furthermore, we based the potential range 
for the constant fu on the assumption that a 
cadmium concentration of 50 mg/kg in kidney 
cortex corresponds to 1.7–2.5 µg cadmium 
per gram of creatinine in urine (Kjellström 
and Nordberg 1978; Nordberg et al. 1985; 
Orlowski et al. 1998). The time step we chose 
for the analysis was 1 year, for practical and 
computational reasons. The deviation due to 
this approximation was found to be negligi-
ble, because the error induced by the use of a 
yearly step was in the worst case < 3% com-
pared with using 1 day as the time step.
Statistical methods and models. Because 
longitudinal data were available for cadmium 
intake, assessed at three different occasions, 
the magnitude of the within-subject variation 
in dietary cadmium intake could be assessed 
by analysis of covariance (ANCOVA). More 
specifically, we performed a trend analysis to 
estimate any linear trend over time of both 
cadmium intake and cadmium intake per 
kilogram of body weight. A linear regression 
of intake was then fitted against age over the 
three time points, with a random effect on 
the subject and accounting for inter  occasion 
variability with a fixed effect on the time point 
(using SAS proc MIXED; SAS version 9.1; 
SAS Institute Inc., Cary, NC, USA). Body 
weights were available at the three time points.
We chose an additive normal model to 
describe measurement error and residual vari-
ance. A Bayesian approach (Gelman et al. 
2004; Wakefield et al. 1994) was used to per-
form the statistical inference, and posterior 
means were used for estimates. The Bayesian 
inference is an efficient alternative to the 
maximum likelihood approach, especially 
in the context of hierarchical (population) 
nonlinear models as presented here. Because 
it allows easy integration of prior informa-
tion on parameters or constraints on them, 
identifiability (or separability) issues may be 
prevented. More details on Bayesian inference 
can be found in the references cited previ-
ously, and in Bernillon et al. (2000) regarding 
its specificity to TK modeling.
For the one-compartment model, the 
parameters to be estimated were t1/2 and fk × fu 
aside from the population parameters. In the 
Bayesian setup, prior distributions need to 
be defined on each model parameter. We set 
a noninformative (uniform) prior between 
5 and 35 years for individual t1/2 values in 
order to constrain the estimation only within 
biologically plausible values. An informative 
prior was set over fk × fu in order to integrate 
the prior knowledge on the cadmium-related 
and physiologic parameters described above. 
This prior was set to a normal distribution 
(truncated at zero) centered on the central 
value given by the literature, and with CV 
= 30% covering the range of possible values 
for fk.
For the eight-compartment model, we 
fitted only the two most sensitive parameters 
(out of the 29) for computational reasons. 
They corresponded to the absorption frac-
tion and the fraction transferred from plasma 
to extravascular fluid, and both were found 
to be slightly higher than the default values. 
For the Bayesian statistical analysis, we used 
only noninformative (flat) priors (restricted to 
positive values); that is, no information other 
than data was used to make the inference.
Monte Carlo Markov chains were used 
for the fitting using WinBUGS version 1.4 
for the one-compartment model (Lunn et al. 
2000), and an ad hoc Metropolis-Hastings 
algorithm (random walk) coded in Matlab 
release 14 (Mathworks, Inc., Natick, MA, 
USA) for the eight-compartment model. 
We used the Gelman-Rubin (Gelman et al. 
2004) coefficient to assess the convergence 
of Markov chains. All other statistical explor-
atory analyses (tests, regressions and data 
management) were performed with SAS ver-
sion 9.1. All graphs and simulations were 
made using Matlab.
The model selection procedure was 
defined as follows. We fitted both models as 
previously described, without any popula-
tion variability. The mean predictions from 
the two fitted models were then compared. 
Only in the case of a substantially better pre-
diction power would the eight-compartment 
model be the model of choice; otherwise, 
the one-compartment model would be used. 
Subsequently, we added variability param-
eters to the chosen TK model. We did not 
pre  specify the intraindividual variability in 
urinary cadmium; instead, we performed a 
sensitivity analysis on the final model to assess 
the consequence of assuming such an addi-
tional interoccasion variability. A population 
layer was added to describe the interindividual 
variability (Rowland et al. 1985; Wakefield Amzal et al.
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et al. 1994), by adding a lognormal random 
effect on half-life parameter(s).
In order to validate the final population 
model, two sensitivity analyses were per-
formed: a) Observed urinary concentrations 
were plotted against the mean individual pre-
dicted ones, and b) A cross-validation was 
performed by first fitting on two-thirds of 
the data and then plotting the population 
predictions against the remaining one-third 
observed concentrations to detect any unde-
sirable pattern or bias.
Last, the model parameters were set to 
their statistical estimates and Monte Carlo 
simulations were run in order to derive the 
population distribution of daily cadmium 
intake required to reach a given level of uri-
nary cadmium after lifetime exposure.
Results
Cadmium intake variability. Table 1 presents 
the major characteristics of the 680 women 
included in the study. The overall average daily 
cadmium intake at the three different occasions 
was 14 µg, similar to that previously reported at 
baseline for all 30,210 post  menopausal women 
(Åkesson et al. 2008). Figure 1 presents the 
major dietary sources of cadmium intake at 
baseline. Because these results agreed with those 
of the entire population-based cohort (data not 
shown), we considered the 680 women in the 
present study representative of upper middle-
age Swedish women.
We found the test for the time trend anal-
ysis (ANCOVA) to be significant for cad-
mium intake (p = 0.02) but not significant 
for the cadmium intake per kilogram of body 
weight (p = 0.17). This result supported our 
assumption of constant cadmium intake per 
kilogram of body weight, at least for the adult 
population. The between-occasion SD for the 
daily intake was found to be about 2 µg/day 
(i.e., about 15% variability between years) 
when assuming that this variability is con-
stant over time. However, such a between-
year variation is expected to underestimate 
Figure 2. Comparison of individual urinary cadmium (U-Cd) predictions using the one-compartment model 
and the eight-compartment model.
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Table 2. Statistical estimates of model parameters and their 95% CIs.
Parameter  Mean posterior estimate  95% CI
Population mean t1/2 (years)  11.6  10.1–14.7
Population SD t1/2 (years)  3.0  2.5–4.0
Factor (fk × fu)  0.005  0.0031–0.0063
Residual variance (µg/g creatinine)2   0.0012  0.0008–0.0020
Figure 3. Estimated distribution of apparent half-life of kidney cadmium in the study population based on 
the one-compartment model and assuming lognormality.
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Figure 1. Major dietary sources of cadmium (%) 
in 680 never-smoking women at baseline (1987) of 
the SMC.
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Table 1. Main characteristics of the 680 women 
participating in the study.
Characteristic  Mean  Median  Range
Age (years)  64  64  56–70
Weight (kg)  69  68  36–124
Daily dietary cadmium intakea 
  1987–2007 (µg)  14  14  9–21
  1987–2007 (µg/kg   0.2  0.2  0.1–0.4
  body weight) 
  1987 (µg)  15  15  8–26
  1997 (µg)  13  13  3–24
  2004–2007 (µg)  13  13  7–27
Urinary cadmium (µg/g   0.34  0.31  0.09–1.23
  creatinine) 
aAdjusted for total energy intake of 1,700 kcal using the 
residual regression method.Variability of cadmium toxicokinetics in humans
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the between-days intake variability. In addi-
tion, the FFQ used for the intake assessment 
may underestimate the intraindividual varia-
tion in food intake, because in most cases 
we predefined the response categories. As a 
consequence, a 25% variability of intraindi-
vidual daily intake was assumed (with normal 
distribution) and integrated into the one-
compartment model.
Model comparison. The mean predictions 
of urinary cadmium using the two models 
were very close (Figure 2). This finding is con-
sistent with a similar conclusion in WHO/
IPCS (1992) regarding model comparison 
between a one-compartment model and a 
PBTK model (the Kjellström and Nordberg 
model in that case). Because the two mod-
els result in essentially the same predictions, 
the eight-compartment cannot be said to 
have a substantially better prediction power. 
Therefore, we chose the one-compartment 
model in the subsequent calculations.
Model fitting based on the SMC data. The 
population one-compartment model was then 
fitted to the SMC data. We ran three paral-
lel Markov chains (> 300,000 simulations) 
in order to obtain the posterior distributions 
of parameters and thereafter their estimates. 
Thinning was set to 10, and the 150,000 
first simulations were viewed as burning 
time (Gelman et al. 2004; Lunn et al. 2000). 
Table 2 reports all statistical estimates. The 
population mean half-life of cadmium in the 
kidney was estimated to be about 11.6 years 
[95% confidence interval (CI) = 10.1–14.7]. 
Figure 3 shows the distribution of the half-life 
in the population (assumed to be lognormal, 
truncated to a range of 5–35 years).
The concordance between measured 
and predicted individual urinary cadmium 
concentrations was very high, as shown in 
Figure 4. The population-based model fitted 
well to the empirical data, except at the low-
est concentrations (< 0.1 µg/g creatinine). In 
the cross-validation (Figure 5), the observed 
versus predicted population variability around 
the population mean shows no obvious bias 
or skewness.
Derivation of the link between cadmium 
intake and lifetime exposure. Based on the 
estimated parameters, we ran Monte Carlo 
simulations in order to predict the population 
variation in urinary cadmium as a function 
of lifetime exposure, for a given daily intake. 
Figure 6 shows the predicted urinary cadmium 
concentrations corresponding to a daily cad-
mium intake of 0.3 µg/kg body weight over 
70 years in the 50th, 95th, and 99th percen-
tiles of the population. The upper percentiles 
represent the individuals at most risk for high 
urinary cadmium concentrations, (mainly) 
because of long retention time in the body.
Based on the model, the population dis-
tribution in the daily cadmium intake corre-
sponding to a given level of urinary cadmium 
could also be obtained. Thus, we calculated 
the population variation in dietary cadmium 
intake corresponding to urinary cadmium 
concentrations of 0.5, 1, 2, and 3 µg/g crea-
tinine, in a 50-year-old individual with 70 
kg body weight (Figure 7), to be used for 
risk assessors. The age of 50 years was cho-
sen because urinary cadmium is considered 
at its maximum at this age in previous risk 
assessments of cadmium (WHO/FAO 2004). 
The curves show, for each population per-
centile, the maximum dietary cadmium 
intakes allowed in order not to exceed the 
predefined urinary cadmium concentrations. 
Thus, in order to remain below, for example, 
1 µg cadmium/g creatinine in urine in 50% 
of the population by the age of 50 (average 
urinary cadmium is 1 µg/g), the average daily 
dietary cadmium intake should not exceed 
about 0.8 µg cadmium/kg body weight. We 
found the corresponding intake for the 95th 
Figure 4. Measured individual urinary cadmium concentrations (U-Cd) versus predicted individual concen-
trations using the one-compartment model.
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percentile of the population remaining below 
1 µg/g to be about 0.4 µg cadmium per kilo-
gram of body weight and per day.
Sensitivity analyses. Unlike the eight-
compartment model, the one-compartment 
model allowed all parameters to be statisti-
cally estimated, implying that the results must 
not depend on fixed default values. Therefore, 
no sensitivity analysis was required in that 
respect. However, we performed sensitivity 
analyses with respect to the modeling assump-
tions, namely, the a priori information cho-
sen for the Bayesian analysis, the choice for 
dietary cadmium intake variability, and the 
description of intraindividual variability.
The Bayesian approach used allowed 
incorporation of some a priori information 
taken from the literature but still considering 
the uncertainty (CV = 30%, normal distri-
bution). We performed a sensitivity analysis 
with respect to the choice of such informa-
tion, using a much less informative (prior) 
distribution on the fk parameter (using CV 
= 100%). The parameter estimates were 
close to the original ones (< 5% difference), 
resulting in no major change in the model 
predictions. Similarly, the model fit was also 
performed without the constraint that the 
population mean half-life should be between 
10 and 30 years. The resulting parameter esti-
mates were also very close to the original ones. 
Table 3 summarizes the parameter estimates 
using those alternative prior distributions.
The interday variability in dietary cad-
mium intake could not be directly estimated 
from the data. To evaluate the impact of 
the assumption we used of 25% variability, 
a sensitivity analysis was performed. We set 
a lower bound for the variability to 15%, 
as actually estimated for the variation data 
over the three data collection periods for the 
dietary intakes. An upper bound of 50% as 
estimated in the NHANES III (1988–1994) 
study by Choudhury et al. (2001) was cho-
sen, where the cadmium intake variability 
(inter  individual intraindividual variability 
over the survey time) was about 50%. The 
results based on the assumed intake variability 
between 15% and 50% showed < 5% differ-
ence in all parameters estimated; that is, we 
found the model to be very robust.
Finally, a sensitivity analysis was also 
performed with respect to additional intra-
individual variability of urinary cadmium 
concentrations, which could not directly be 
estimated from the data. In the final model, 
we estimated the residual variance to be 
about CV = 13% on average of the urinary 
cadmium measured. This variance encom-
passes mainly the intraindividual variability 
(e.g., intra  occasion variation), but also some 
meas  urement error. This may be too small, 
so some of this intraindividual variability 
may have been transferred into the popula-
tion variability, hence inflating the variability 
shown in Figure 6. In order to assess what 
would be the outcome of a similar analysis 
but fixing some predetermined interoccasion 
variability, we added an additional variance 
term in the error model, which we set as a 
multiplicative (lognormal) error with CV = 
25%, hence describing an additional 25% 
variability of urinary cadmium concentrations 
within subjects. A similar statistical inference 
was subsequently performed. The resulting 
fit was not as good as the fit without this new 
assumption, especially for urinary cadmium 
concentrations > 0.4 µg/g creatinine, leading 
to a consistent underestimation of the model 
(Figure 8). Although the data do not fully 
support this new assumption, the parameter 
estimates could be derived. We estimated the 
Figure 6. Predicted urinary cadmium concentrations corresponding to a daily cadmium intake of 0.3 µg/
kg body weight over 70 years in the 50th, 95th and 99th percentiles of the population, overlaid by the data 
(circles) after adjustment to an intake of 0.3 µg/kg body weight.
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new mean half-life to be 11.6 years (95% CI 
= 9.3–16) and the new intersubject variability 
to 2.7 years (95% CI = 2–4). As expected, the 
intersubject variability had been transferred to 
intrasubject variability, although in a moder-
ate way. The 5th percentiles of daily cadmium 
intake needed to achieve a given urinary cad-
mium value were seen to be relatively robust 
with respect to this extravariability assump-
tion (~ 10% higher when such a variability is 
taken into account).
Discussion
This study is the first to evaluate, on a popu-
la  tion level, the variability in cadmium kinet-
ics using paired individual data on dietary 
intake and urinary excretion. Our results 
clearly demonstrate the need to consider the 
large variation in cadmium kinetics when 
translating biomonitoring data such as uri-
nary cadmium into data on dietary intake 
of cadmium. The one-compartment TK 
model proved to be as suitable as the eight-
  compartment model to fit urinary cadmium 
data and provides additional flexibility to 
allow for population   variability modeling.
In this study of 680 Swedish women, the 
estimated average daily cadmium intake of 
14 µg was similar to that observed in Europe 
and the United States in areas with no indus-
trial cadmium contamination (Berglund et al. 
1994; Egan et al. 2007; Larsen et al. 2002; 
Llobet et al. 2003; MacIntosh et al. 1996; 
Olsson et al. 2002; Thomas et al. 1999; Ysart 
et al. 2000). Furthermore, the dietary cad-
mium intake of the women was considered 
to be representative of upper middle-aged 
Swedish women (Åkesson et al. 2008).
The major advantage of the present study 
is the availability of both long-term intake 
and biomarker data at the individual level, 
allowing individual linking of intake to uri-
nary cadmium concentrations and estimation 
of the population variations. This allowed, 
for the first time, the assessment of the 
between-person variability in cadmium TK 
at the popu  lation level, hence allowing the 
derivation of a robust model to be used in 
risk assessment. Figures 3 and 4 illustrate how 
the model can capture such variability. This 
procedure also permits the quantification of 
the link between cadmium intake and urinary 
cadmium at the individual level, making pos-
sible more exact individual predictions.
In a previous U.S. study (Choudhury 
et al. 2001; Diamond et al. 2003), the associa-
tion between urinary cadmium and cadmium 
intake was assessed based on NHANES III 
(1988–1994). The study provided empirical 
mean estimates of urinary cadmium and cad-
mium intake over the U.S. population, strati-
fied by age groups and by sex. Choudhury 
et al. (2001) and Diamond et al. (2003) also 
predicted the central tendency of urinary 
cadmium from the mean daily cadmium 
intake using the eight-compartment model 
as described by Nordberg et al. (1985). The 
main advantage of the U.S. study was that 
they were able to evaluate the entire U.S. 
population in terms of different age strata in 
both men and women and could assess and 
account for cadmium intake variability. On 
the other hand, although available, individual 
cadmium intake and urinary cadmium could 
not be paired for the evaluation of interindi-
vidual variability in toxicokinetics. The 24-hr 
recall method used for intake measurement in 
the NHANES survey may be a more impre-
cise proxy of long-term cadmium intake than 
the FFQ method used in the SMC study.
The urinary cadmium concentrations in 
the NHANES III data for women 40–60 years 
of age was about 0.55 µg/g creatinine, corre-
sponding to a daily intake of 0.3 µg/kg body 
weight. By using the default parameter val-
ues in the eight-compartment model (with 
a 5% absorption coefficient), Choudhury 
et al. (2001) arrived at a predicted urinary 
cadmium concentration of 0.3 µg/g creati-
nine, which was in good agreement with the 
NHANES III measured average value for men 
but clearly underestimated the urinary con-
centrations for women. A likely explanation 
is the higher absorption rate in women (up to 
10%). At the same intake level of 0.3 µg cad-
mium per day per kilogram of body weight, 
the predicted urinary cadmium based on our 
model was 0.39 µg/g creatinine for a median 
individual (50th percentile in Figure 6) but 
was 0.43 µg/g creatinine when we averaged 
the predictions over the population, which 
is consistent with the U.S. data. Thus, the 
results might indicate an average absorption 
rate in women > 5% but < 10%. The differ-
ence, although not statistically significant, 
between the 0.55 µg cadmium/g creatinine 
measured in urine in the NHANES III and 
the mean of 0.43 µg/g creatinine estimated 
by the model based on our data could also be 
due to other differences in population charac-
teristics or differences in intake measurement 
methods.
Further strengths of our study were the 
large number of individuals (680) and our 
ability to create a detailed food-cadmium 
database based on the cadmium content in 
practically all foods available on the Swedish 
market. The data were provided by the NFA, 
Table 3. Comparison of the parameter estimates (posterior means and 95% CIs) when using the original 
prior, when using the same prior but with inflated variance (CV = 100% instead of 30%), and when using a 
prior on the population mean t1/2 without any bounds.
  Mean posterior (95% CI)
    Prior on (fk × fu) with  Prior on population
    inflated variance (CV =    mean t1/2 not bounded
Estimate  Using the original priors  100% instead of 30%)  by 10 and 30 years
Population mean t1/2 (years)  11.6 (10.1–14.7)  11.5 (10.1–16.3)  11.3 (9.5–15.3)
Population SD t1/2 (years)  3.0 (2.5–4.0)  3.0 (2.5–4.5)  2.9 (2.3–4.2)
Factor (fk × fu)  0.005 (0.0031–0.0063)  0.005 (0.0026–0.0063)  0.0052 (0.0029–0.0070)
Residual variance (µg/g creatinine)2  0.0012 (0.0008–0.0020)  0.0012 (0.0008–0.0020)  0.0012 (0.0008–0.0013)
Figure 8. Measured individual urinary cadmium (U-Cd) concentrations versus individual predictions from 
the one-compartment population model, using additional 25% intraindividual variability on U-Cd.
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which has monitored cadmium content in 
food (up to several hundred analyses per 
food item) repeatedly over the past decades 
(Becker and Kumpulainen 1991; Jorhem and 
Sundstrom 1993; Jorhem et al. 2001).
A possible limitation associated with the 
present study may be that the dietary cad-
mium intake was estimated based on an FFQ, 
providing a rather rough measure of the cad-
mium intake levels of the individuals. On 
the other hand, the validation based on the 
consumption of major cadmium-contributing 
foods in a subgroup of the women and that 
based on biological markers in another popu-
lation were satisfactory. The use of the aver-
age cadmium concentration for each food 
item in the questionnaire was substantiated 
by the fact that there is no known industrial 
cadmium contamination of agricultural soil 
in the study area and no known geographical 
variation in cadmium content of consumed 
foods across Sweden. In addition, most foods 
are distributed throughout the country by 
wholesale companies, giving a fair representa-
tion of what the women in our study would 
encounter. We might, however, not have full 
access to all interday variability in the cad-
mium intake as assessed by the FFQ; instead, 
we estimated and accounted for the popula-
tion variability in the half-life of cadmium in 
the kidney, in addition to the intraindividual 
intake variability that we fixed at 25%.
Furthermore, the assumption of constant 
cadmium intake per kilogram of body weight 
over a lifetime could also be challenged, espe-
cially for younger ages. However, considering 
the estimated half-life (~ 12 years) and the 
age range of our study population (> 50 years 
of age), even large variations of intake before 
20 years of age are expected to have limited 
impact on the cadmium burden at older ages. 
Based on the model estimates, thus, a varia-
tion of 50% in cadmium intake until 15 years 
of age would, based on our model estimates, 
result in < 3% difference in the cadmium 
burden at 50 years of age. Finally, the adjust-
ment to a constant energy intake of 1,700 kcal 
(mean intake recorded in the FFQ) may 
underestimate the cadmium intake, because 
energy expenditure can be expected to be up 
to 15% higher [WHO/FAO/United Nations 
University 2001]. 
Another limitation is that the population 
variability estimates may be biased because 
they derive from older women only. However, 
including women is appropriate for risk assess-
ment purposes because women generally have 
higher concentrations of cadmium in blood, 
urine, and kidney than do men, because of 
higher gastrointestinal cadmium absorp-
tion (Vahter et al. 2007). Thus, women are 
considered more at risk of adverse effects of 
cadmium, and protecting them would likely 
protect the entire population.
Finally, other sources of variability and 
biases related to both TK and intake lead to 
variations over a lifetime that were not pos-
sible to account for.
Interestingly, because of the simple form 
of the model, any systematic bias made over 
the population on, for example, intake or 
absorption rate will not have any impact on 
the final outputs because it would only cor-
respond to an additional factor within fk × fu 
to be globally estimated. As a consequence, the 
biological interpretation of the fk × fu results 
may not be meaningful. This illustrates a com-
mon difference between such a population 
one-compartment model and more physiolog-
ically based models in which each parameter 
clearly corresponds to one physiologic vari-
able. Similarly, all the population variability 
has been imputed to the half-life parameter. 
Accounting for an additional population vari-
ability, for example, on absorption (i.e., on 
fk × fu) leads to an overparameterized model 
that cannot be fitted to the available data. This 
choice of parameterization may result in some 
inflation of the population variance of the cad-
mium half-life, which is of no consequence 
for the risk assessment objectivebut should be 
acknowledged for the biological interpreta-
tion. Indeed, this apparent variability may still 
encompass some variability, for example, in 
absorption rate. Figures 4 and 6 indicate that 
most population variability has been captured 
by the model.
Conclusions
The population modeling of a large database 
of individually matched long-term cadmium 
intake and urinary cadmium concentrations 
was a helpful tool for human risk assessment. 
More specifically, we showed the following:
•	A	one-compartment	TK	model	could	provide	
prediction of individual urinary cadmium 
sensibly similar to that of a PBTK model.
•	A	population	one-compartment	model	
allowed integration and quantification of 
the between-person variability in cadmium 
TK, in particular, the population mean half-
life of cadmium in the kidney.
•	The	population	distribution	of	daily	cad-
mium intakes corresponding to a predefined 
urinary cadmium concentration could be 
derived in a robust manner. The deriva-
tion of a maximum daily cadmium intake 
would ensure that 95% of the most vulner-
able population subgroups do not reach a 
predefined level of cadmium body burden, 
which is crucial to support risk assessment.
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